drugset / Trial / NCT01152021

Comparing Safety and Efficacy of Dexmedetomidine and Propofol

NCT01152021

Phase 3 Terminated 15 enrolled Boston Children's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective, open label randomized study. The purpose of this study is to compare propofol with dexmedetomidine for pediatric monitored anesthesia care for MRI, specifically identifying important patient demographics and looking at important outcomes including adverse events.

Timeline

Start
2011-08
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1.5 ug/kg
Comparator Propofol Small molecule 300 ug/kg

Indications

No indication recorded.